Platinum antitumour agents: A review of (bio)analysis T. J. M. HodesW. J. M. UnderbergJ. H. Beijnen Reviews Pages: 61 - 77
Clinical and pharmaceutical aspects in acute poisoning R. G. Van KesterenD. R. A. Uges Reviews Pages: 78 - 82
Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans T. B. VreeE. W. J. Beneken Kolmer Articles Pages: 83 - 87
Centralized preparation of hazardous drugs P. LarrouturouJ. HuchetM. -C. Taugourdeau Practice/Case Reports Pages: 88 - 92
Hydrocortisone anaphylaxis: A new case report N. CorominasJ. M. MañéJ. Ribas Practice/Case Reports Pages: 93 - 94
Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity Heinz NauH. Siemes OriginalPaper Pages: 101 - 107
Influence of co-medication on the metabolism of valproate Francesco Pisani OriginalPaper Pages: 108 - 113
Pharmacokinetics of valproate in pregnancy: Mother-foetus-newborn Svein I. Johannessen OriginalPaper Pages: 114 - 117
Valproate hepatotoxicity syndrome: Hypotheses of pathogenesis Jeffrey R. StephensRené H. Levy OriginalPaper Pages: 118 - 121
Metabolism of valproate to hepatotoxic intermediates Thomas A. Baillie OriginalPaper Pages: 122 - 125
Neural tube defects in association with epilepsy and its treatment D. Chadwick OriginalPaper Pages: 126 - 126
Effects of valproate on xenobiotic biotransformation in rat liver V. RogiersA. CallaertsI. Phillips OriginalPaper Pages: 127 - 131
Strategies for identifying and developing new anticonvulsant drugs Harvey J. Kupferberg OriginalPaper Pages: 132 - 138
Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals Wolfgang Löscher OriginalPaper Pages: 139 - 143
Pharmacological, toxicological and neurochemical effects of Δ2(E)-valproate in animals Peter E. Keane OriginalPaper Pages: 144 - 145
Δ2-Valproate biotransformation using human liver microsomal fractions Gérard FabreChristophe BriotJean -Paul Cano OriginalPaper Pages: 146 - 151
Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in healthy male volunteers R. H. Düsing OriginalPaper Pages: 152 - 158
Studies on 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in man Lennart Gram OriginalPaper Pages: 159 - 160